Trial Profile
A phase 3 clinical trial evaluating efficacy and safety of febuxostat in cancer chemotherapy patients with malignant tumors.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Tumours
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2016 New trial record